Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and ...
Ocugen, Inc. (NASDAQ: OCGN) is stepping into one of biotech’s most important global spotlights, with its top executive set to ...
Scanning a simaris target for a riven doesn't have to be hard, even with all the modifiers seemingly stacked against you. Just follow these steps! Thumbnail expertly crafted by Bibiscular Designs.